Can you tell us what facilities AstraZeneca built in the U.S. to manufacture the COVID vaccine. It appears that all the manufacturing for the most part is being done in India - most of it by Serum. For the most part AstraZeneca merely warehoused doses in the U.S. Emergent BioSolutions located in Maryland which was contracted to produce AstraZeneca doses for the U.S. market has not started to produce any yet -- and appears they will get into motion if the FDA EUA approval of AstraZeneca is imminent. There is also the high probability that the FDA could reject the AstraZeneca vaccine (article from one month back before the blood clot issue came up.) FDA could reject AstraZeneca's COVID-19 vaccine on efficacy and manufacturing shortfalls https://www.fiercepharma.com/pharma...efficacy-and-manufacturing-shortfalls-analyst
Refer to one of my last set of comments from yesterday on that topic. AstraZ is dead in the water. The administration has tilted against them. They will need to jump through some hoops real or perceived and the market timing is now against them. Moderna is Fauci's vaccine. Pfzier and Moderna and JandJ are now the favored ones - although it should be noted that they all had problems or negative press at various points, and Merk is producing for J and J now since it cancelled its own vaccine. But as I said yesterday AstraZ may still decide to produce from its faciliities in the U.S and export to the countries where there is a market or a better market. One unfortunate aspect of this whole AstraZ flap- worldwide- is that various media sources are reporting that many third world countries that were slated to get AstraZ are now leaning away from it in favor of Sinopharm. I dont like to see that. It plays into the hands of the chinese and in addition the Chinese vaccines are highly untested but not getting bad press. AstraZ is getting problems that come with the laws of large numbers. That's all. And all of the vaccines that are in current use will go through it at various times. But yeh, AstraZ is on the downcurve in the U.S. The US is more or less settling on what it thinks the winners are. I am old enough to remember just a few months ago when Pfizer was considered to be shiite and useless because of its storage requirements. And Moderna was looking iffy and was being turned on and off because someone's dick fell off or something. Then J and J was allegedly shiite because it was allegedly only 55% effective, and then a month later it was a winner. Whatever, this stuff runs in cycles. It is more fatal to a vaccine if the country already has other options, which is happening to AstraZ in the U.S. If you live in Canada, well, refer to my comment about not having other choices. It looks better to you.
I am not going to do the research for you. But their Baltimore location was/is one of the prime locations where they are/were planning to do major production. Also, be careful about researching AstraZ vaccines. They have two or more going. One of the AstraZ vaccines is produced in India in partnership with India but just for third world markets or Canadians too I guess. I don't believe that is the same AstraZ vaccine being used in the European market so be careful to not do too much mix and match if you are googling around. I think the Canadians will be getting two types of AstraZ vaccine. One that is what is called "the Indian vaccine" in the press, and now the AstraZ from the U.S which is, I think, the same as the European AstraZ.
Today's hint -- your claim that AstraZeneca doses were being manufactured in the U.S. is absolutely false. I am not going to do your research for you. We both know your claim is false. Go do the work to prove me wrong. I have already provided the inline links proving my assertion.
AstraZeneca: German team discovers thrombosis trigger Scientists at Greifswald teaching hospital claim they have discovered the cause of blood clots among a small number of AstraZeneca vaccine recipients. Doctors say a targeted treatment can now be used. https://www.dw.com/en/astrazeneca-german-team-discovers-thrombosis-trigger/a-56925550 Researchers at the Greifswald teaching hospital in northern Germany said on Friday that they had discovered the cause of the unusual blood clotting found in some recipients of the AstraZeneca coronavirus vaccine, public broadcaster Norddeutscher Rundfunk (NDR) reported. The investigation showed how the vaccine caused rare thrombosis in the brain in a small number of patients. The discovery means that targeted treatment can be offered to those who suffer similar clotting, using a very common medication. The success was a result of cooperation between the Greifswald hospital, state health regulator the Paul Ehrlich Institute (PEI), as well as doctors in Austria — a nurse there died from thrombosis in the brain after being vaccinated with the AstraZeneca jab. The researchers emphasized that treatment would only be possible in patients where blood clots appear, rather than as a preventative treatment. The information has been shared with hospitals around Europe. Symptoms like continuous headache, dizziness or impaired vision lasting more than three days after vaccination need further medical check-ups, according to the German Research Association for Thrombosis and Hemostasis in a statement on the recent findings. The Greifswald findings have not yet been published in a scientific journal and therefore have not been reviewed by independent experts. The Paul-Ehrlich-Institute in Germany is now looking into the scientists' work. AstraZeneca jabs back on track in Europe Germany, along with several other EU member states, suspended the use of the AstraZeneca vaccine on Monday following reports of unusual blood clots. On Thursday the European Medicines Agency (EMA) said that there were no proven links between the vaccine and the clots, based on the information they had. They also stated that the benefits of the jab outweighed any possible risks. In response to the updated guidance, Germany was set to restart vaccinations with the British-Swedish jab on Friday. By Thursday, Germany had administered over 10 million doses of COVID-19 vaccines, including the AstraZeneca vaccine.
I don't know what you are on the rag about. I am just contributing to the discussion with some general points but you are apparently desperate to be right about something before the week is over. In the meantime, I said a couple times that I believed that AstraZ was producing in the US of preparing to produce somewhere either in Ohio or Baltimore. I see this in the New York Times but maybe I am hallucinating. I dont care. Either way my dick is not going to fall off. I was just making a general point that I believe is generally true. You are looking to defend Biden or some agenda. Perhaps, you can explain this away, from the New York Times which sounds surprisingly like the very same Ohio and Baltimore that I mentioned while also saying I was not sure. "About 30 million doses are currently bottled at AstraZeneca’s facility in West Chester, Ohio, which handles “fill-finish,” the final phase of the manufacturing process during which the vaccine is placed in vials, one official with knowledge of the stockpile said. Emergent BioSolutions, a company in Maryland that AstraZeneca has contracted to manufacture its vaccine in the United States, has also produced enough vaccine in Baltimore for tens of millions more doses once it is filled into vials and packaged, the official said"
COVID-19: Science behind Pfizer-BioNTech vaccine can be used to give people cancer jabs 'within a couple of years', says co-creator The technology used to develop the Pfizer jab can be applied to get the immune system to take on tumours, says its co-creator. https://news.sky.com/story/covid-19...in-a-couple-of-years-says-co-creator-12250692 The co-creator of Pfizer's coronavirus vaccine has said the technology behind it could soon be used to fight cancer too. While the vaccine has been bankrolled by the American pharmaceutical giant, the science itself is the work of BioNTech, a German company founded by married couple and dedicated physicians Ugur Sahin and Ozlem Tureci. Dr Tureci was working on a way to harness the body's immune system to tackle tumours when the pair learned last year of a mystery virus infecting people in China. Over breakfast, they decided to apply the technology they'd been researching for two decades to the new threat, dubbing the effort "Project Lightspeed." Both COVID-19 vaccines Pfizer/BioNTech and Moderna use messenger RNA (mRNA) to send genetic instructions to the human body's cells for making proteins that prime it to attack the coronavirus. The same principle can be applied to get the immune system to take on tumours. "We have several different cancer vaccines based on mRNA," Dr Tureci told the Associated Press. Asked when such a therapy might be available, she replied: "That's very difficult to predict in innovative development. But we expect that within only a couple of years, we will also have our vaccines (against) cancer at a place where we can offer them to people." On Friday, German President Frank-Walter Steinmeier awarded the wife and husband one of the country's highest decorations, the Order of Merit, during a ceremony attended by Chancellor Angela Merkel. "You began with a drug to treat cancer in a single individual," Mr Steinmeier told the couple. "And today we have a vaccine for all of humanity." Dr Tureci said ahead of the ceremony that getting the award was "indeed an honour", but insisted developing the vaccine was the work of many. "It's about the effort of many: our team at BioNTech, all the partners who were involved, also governments, regulatory authorities, which worked together with a sense of urgency," she said. "The way we see it, this is an acknowledgement of this effort and also a celebration of science." Coming from humble beginnings as children of immigrants, scientists and entrepreneurs Professor Sahin, 55, and Dr Tureci, 53, are now among the 100 richest Germans, with the value of their company BioNTech soaring to $21bn (£16bn) in the wake of the vaccine breakthrough. Mr Sahin, who was born in Turkey and is a trained doctor, is the chief executive officer of BioNTech, and turned his focus to researching immunotherapy. Dr Tureci, who is the company's chief medical officer, was born in Germany and is the daughter of a Turkish physician who migrated to the country from Istanbul.
CDC report: Disparities in COVID-19 vaccinations seen in 'majority' of states, vulnerable counties impacted most https://news.yahoo.com/cdc-report-disparities-covid-19-132159634.html